Advancing Diverse Representation in Clinical Trials and Research

HealthVerity offerings support the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research.

Patient monitoring amid COVID-19: HPVCI reaches a milestone of 98

Patient monitoring amid COVID-19: HPVCI reaches a milestone of 98

October 19, 2020 - Philadelphia, PA - HealthVerity announced the most recent update to its HealthVerity Patient Confiden...

HealthVerity joins Time to Vote movement

HealthVerity empowers fourteen team members to form the Equity, Inclusion and Diversity (EID) Council as a means to cele...

The power of interoperability: how to eliminate healthcare data silos

The “acceleration of digital health transformation” means many things to many people, but through the perspective of Hea...

Innovation DNA and the building blocks to recovery

“COVID-19 has impacted nearly every organization—from enterprise to startup—and their strategies for growth. Right now, ...

HVPCI reaches “pre-pandemic levels” with highest score to date

September 17, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidenc...

Clinical Trial Diversity: Solutions for Underrepresentation

Racial diversity in clinical trial populations has been a prominent challenge for years, but most recently the inequalit...

HPVCI surges to the highest level of the year

September 3, 2020 - Philadelphia, PA - HealthVerity announced the biweekly update to its HealthVerity Patient Confidence...

Subscribe to the HealthVerity blog

Contact us